Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Asymptomatic Carotid Surgery Trial
ISRCTN ISRCTN26156392
DOI 10.1186/ISRCTN26156392
ClinicalTrials.gov identifier
EudraCT number
Public title Asymptomatic Carotid Surgery Trial
Scientific title
Acronym ACST
Serial number at source G9408332
Study hypothesis The aim is to determine whether CEA and BMT improve stroke-free survival time when compared to BMT alone. The trial will also help identify high-risk groups in whom the benefits of surgery and of BMT would be increased
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Carotid stenosis
Participants - inclusion criteria Patients whose carotid stenosis has not caused symptoms for at least 6 months, who have no past history of ipsilateral disabling or severe contralateral stroke and have no clear indications or contraindications to carotid endarterectomy (CEA)
Participants - exclusion criteria 1. Patients with a small likelihood of worthwhile benefit e.g. those with major life-threatening disease.
2. Patients who have had recent myocardial infarct, intracerebral neoplasia or aneurysm, or restenosis of an artery following previous CEA
Anticipated start date 01/04/1993
Anticipated end date 31/03/2004
Status of trial Completed
Patient information material
Target number of participants 3120
Interventions CEA and best medical treatment (BMT) vs BMT alone

Added 19/08/08: follow-up is minimum of 5 years
Primary outcome measure(s) Fatal and non-fatal stroke and death rates in medical treatment and surgery group versus medical treatment alone
Secondary outcome measure(s) Subsidiary analyses in an effort to identify high and low risk groups will include the effect of risk factors such as presence or absence of silent cerebral infarction on clinical outcome
Sources of funding Medical Research Council (MRC) (UK)
Trial website http://www.acst.org.uk/acst-1_results/index.php
Publications 1. 2004 results in http://www.ncbi.nlm.nih.gov/pubmed/15135594
2. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20870099
Contact name Miss  Alison  Halliday
  Address ACST, Department of Cardiological Sciences
St George's Hospital Medical School
Cranmer Terrace
  City/town London
  Zip/Postcode SW17 0RE
  Country United Kingdom
  Email
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 23/10/2000
Last edited 27/10/2010
Date ISRCTN assigned 23/10/2000
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.